0001209191-19-025415.txt : 20190419
0001209191-19-025415.hdr.sgml : 20190419
20190419214159
ACCESSION NUMBER: 0001209191-19-025415
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180305
FILED AS OF DATE: 20190419
DATE AS OF CHANGE: 20190419
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Long Andrew G
CENTRAL INDEX KEY: 0001714880
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35902
FILM NUMBER: 19758446
MAIL ADDRESS:
STREET 1: 1333 SOUTH SPECTRUM BLVD, SUITE 100
CITY: CHANDLER
STATE: AZ
ZIP: 85286
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Insys Therapeutics, Inc.
CENTRAL INDEX KEY: 0001516479
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 510327886
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10220 SOUTH 51ST STREET
STREET 2: SUITE 2
CITY: PHOENIX
STATE: AZ
ZIP: 85044
BUSINESS PHONE: 602-910-2617
MAIL ADDRESS:
STREET 1: 10220 SOUTH 51ST STREET
STREET 2: SUITE 2
CITY: PHOENIX
STATE: AZ
ZIP: 85044
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-03-05
0
0001516479
Insys Therapeutics, Inc.
INSY
0001714880
Long Andrew G
1333 S SPECTRUM BLVD #100
CHANDLER
AZ
85286
0
1
0
0
Chief Financial Officer
Common Stock
2018-03-05
4
A
0
10600
0.00
A
20600
D
Common Stock
2019-01-25
4
A
0
29000
0.00
A
49600
D
Employee Stock Option (right to buy)
8.06
2018-03-05
4
A
0
42400
0.00
A
2028-03-04
Common Stock
42400
42400
D
Employee Stock Option (right to buy)
3.81
2019-01-25
4
A
0
173000
0.00
A
2029-01-24
Common Stock
173000
173000
D
The total reported in Column 5 includes 15,000 RSUs previously reported in Table II on the Form 4 filed 8/17/17.
The option vests in 48 equal monthly installments and will be fully vested and exercisable on March 5, 2022.
The option vests in 48 equal monthly installments and will be fully vested and exercisable on January 25, 2023.
/s/ Andrew Long
2019-04-19